BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:GMT Standard Time
BEGIN:STANDARD
DTSTART:20251002T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=10
TZNAME:GMT Standard Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=1;BYMINUTE=0;BYMONTH=3
TZNAME:GMT Daylight Time
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Date: Wednesday 25th November 2020\nTime: 14:00 - 15:00 GMT\nSp
 eakers: Graham Healey (Oncimmune) and Dea Putri (Janssen)\n\nWho is this e
 vent intended for?&nbsp\;Anybody involved in the development and deploymen
 t of biomarkers in pharmaceutical or diagnostic areas.\n\nWhat is the bene
 fit of attending?&nbsp\;To gain an appreciation of the range of issues at 
 the non-clinical end.\nRegistration\nYou can now register for this event. 
 Registration will close at 12:00 on 24th November 2020.&nbsp\;\nThis event
  is&nbsp\;free of charge&nbsp\;to both Members and Non Members of PSI.\nTo
  register your place\, please click here.\nOverview\nThe deployment of bio
 markers in drug development and diagnostics has many challenges ranging fr
 om analytical validation\, in vivo study design\, to the translation to hu
 man utility and financial considerations. In this Webinar focus will be gi
 ven to safety biomarkers. Statistical issues in data science that nonclini
 cal statisticians might encounter along the way will be discussed.&nbsp\;\
 nSpeakers\n\n\n\n    \n        \n            \n            Speaker: Graham
  Healey\n            Biography: Graham has 40 years experience in supporti
 ng R&amp\;D in the pharmaceutical and diagnostics industries\, particularl
 y in the areas of discovery\, toxicology\, assay validation and clinical t
 rials. After graduating in Zoology from Imperial College\, he then convert
 ed to full-time statistics via the MSc Biometry course at Reading. After a
  year lecturing at Bunda Agricultural College deep in the Malawian bush\, 
 he joined the biotech division of G.D.Searle UK\, working on interferon an
 d aspartame. Next came six years at Searle's R&amp\;D site in Belgium foll
 owed by 16 years as Head of Statistics at HLS in UK\, working in a vast ar
 ray of preclinical\, toxicology and clinical areas. He is currently Chief 
 Statistician at Oncimmune Ltd\, involved in all stages of the commercialis
 ation of blood tests for the early detection of cancer\, from laboratory b
 ench to doctor&rsquo\;s surgery. In his spare time his main passions are c
 lassical music and insects.\n            \n        \n        \n           
  \n            Speaker: Dea Putri\n            Biography: Right after grad
 uating from her master study in biostatistics at Hasselt University\, Belg
 ium\, Dea directly joined the discovery statistics at Janssen Pharmaceutic
 a in 2015 as biostatistician. In this role\, Dea closely collaborates with
  other statisticians as well as scientist from different therapeutic area 
 to provide solutions from day to day business needs to a more specific cas
 es which need tailor-made analysis. Dea is building her expertise in high 
 dimensional data integration on pre-clinical as well as clinical studies. 
 At the moment\, Dea is also finishing her doctoral school at Hasselt Unive
 rsity under supervision of Prof. Ziv Shkedy and Prof. Luc Bijnens with res
 earch topic related to statistical method development for the design and s
 tatistical analysis of high dimensional data integration.\n            \n 
        \n    \n\n&nbsp\;
DTEND:20201125T150000Z
DTSTAMP:20260913T051004Z
DTSTART:20201125T140000Z
LOCATION:
SEQUENCE:0
SUMMARY:PSI ToxSIG Webinar: Biomarkers in Toxicology
UID:RFCALITEM639248730044529327
X-ALT-DESC;FMTTYPE=text/html:<strong>Date: </strong>Wednesday 25th November
  2020<br />\n<strong>Time:</strong> 14:00 - 15:00 GMT<br />\n<strong>Speak
 ers:</strong> Graham Healey <em>(Oncimmune)</em> and Dea Putri <em>(Jansse
 n)<br />\n<br />\n</em><strong>Who is this event intended for?</strong>&nb
 sp\;Anybody involved in the development and deployment of biomarkers in ph
 armaceutical or diagnostic areas.\n<br />\n<strong>What is the benefit of 
 attending?</strong>&nbsp\;To gain an appreciation of the range of issues a
 t the non-clinical end.\n<h4>Registration</h4>\n<p>You can now register fo
 r this event. Registration will close at 12:00 on 24th November 2020.&nbsp
 \;<br />\nThis event is&nbsp\;free of charge&nbsp\;to both Members and Non
  Members of PSI.<br />\nTo register your place\, please <a href="https://m
 embers.psiweb.org/Core_Content_PSI/Events/Event_Display.aspx?EventKey=229"
  target="_blank"><strong>click here</strong></a>.</p>\n<h4>Overview</h4>\n
 <p>The deployment of biomarkers in drug development and diagnostics has ma
 ny challenges ranging from analytical validation\, in vivo study design\, 
 to the translation to human utility and financial considerations. In this 
 Webinar focus will be given to safety biomarkers. Statistical issues in da
 ta science that nonclinical statisticians might encounter along the way wi
 ll be discussed.&nbsp\;</p>\n<h4>Speakers</h4>\n<table border="1" cellspac
 ing="0" cellpadding="0">\n</table>\n<table class="table table-striped tabl
 e-bordered">\n    <tbody>\n        <tr>\n            <td valign="top" styl
 e="width: 601px\;">\n            <p><strong>Speaker:</strong> Graham Heale
 y</p>\n            <p><strong>Biography:</strong> Graham has 40 years expe
 rience in supporting R&amp\;D in the pharmaceutical and diagnostics indust
 ries\, particularly in the areas of discovery\, toxicology\, assay validat
 ion and clinical trials. After graduating in Zoology from Imperial College
 \, he then converted to full-time statistics via the MSc Biometry course a
 t Reading. After a year lecturing at Bunda Agricultural College deep in th
 e Malawian bush\, he joined the biotech division of G.D.Searle UK\, workin
 g on interferon and aspartame. Next came six years at Searle's R&amp\;D si
 te in Belgium followed by 16 years as Head of Statistics at HLS in UK\, wo
 rking in a vast array of preclinical\, toxicology and clinical areas. He i
 s currently Chief Statistician at Oncimmune Ltd\, involved in all stages o
 f the commercialisation of blood tests for the early detection of cancer\,
  from laboratory bench to doctor&rsquo\;s surgery. In his spare time his m
 ain passions are classical music and insects.</p>\n            </td>\n    
     </tr>\n        <tr>\n            <td valign="top" style="width: 601px\
 ;">\n            <p><strong>Speaker:</strong> Dea Putri</p>\n            <
 p><strong>Biography:</strong> Right after graduating from her master study
  in biostatistics at Hasselt University\, Belgium\, Dea directly joined th
 e discovery statistics at Janssen Pharmaceutica in 2015 as biostatistician
 . In this role\, Dea closely collaborates with other statisticians as well
  as scientist from different therapeutic area to provide solutions from da
 y to day business needs to a more specific cases which need tailor-made an
 alysis. Dea is building her expertise in high dimensional data integration
  on pre-clinical as well as clinical studies. At the moment\, Dea is also 
 finishing her doctoral school at Hasselt University under supervision of P
 rof. Ziv Shkedy and Prof. Luc Bijnens with research topic related to stati
 stical method development for the design and statistical analysis of high 
 dimensional data integration.</p>\n            </td>\n        </tr>\n    <
 /tbody>\n</table>\n<p>&nbsp\;</p>
END:VEVENT
END:VCALENDAR